Response to Glucagon in Small-for-dates Hypoglycaemic and Non-hypoglycaemic Newborn Infants [PDF]
M. A. Le Dune
openalex +1 more source
Delayed presentation of a retained colonic segment in a child with intestinal failure on teduglutide
Abstract Teduglutide is a glucagon‐like peptide 2 (GLP‐2) analogue that was approved by the United States Food and Drug Administration for the treatment of pediatric (>1 year) intestinal failure due to short bowel syndrome in 2019. GLP‐2 analogues promote rapid intestinal adaptation, increasing the absorptive capacity of residual intestine after ...
Rachel C. Bordelon+6 more
wiley +1 more source
Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report. [PDF]
Stojkovska A+2 more
europepmc +1 more source
Neutralization of Glucagon by Antiserum as a Tool in Glucagon Physiology [PDF]
Jens J. Holst, H. Galbo, Erik A. Richter
openalex +1 more source
Pig bile powder maintains blood glucose homeostasis by promoting glucagon-like peptide-1 secretion <i>via</i> inhibiting farnesoid X receptor. [PDF]
Sun YM+11 more
europepmc +1 more source
Insulin, glucagon, peptide and amino acid levels following liver transplantation [PDF]
Conte, D+9 more
core
Abstract Purpose Total knee arthroplasty (TKA) is a frequently performed surgical procedure aimed at reducing pain, improving mobility, and restoring function in patients with advanced knee osteoarthritis. As patients undergoing TKA age, the prevalence of comorbidities, particularly diabetes, continues to rise.
Yaara Berkovich+6 more
wiley +1 more source
The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years. Aims We aimed to describe the milestones of the gut‐brain axis research in PD and the development of theories proposing the involvement of the ...
Elisa Menozzi+2 more
wiley +1 more source
Natural Peptides Versus Semaglutide: A Safer Approach to Obesity Management
This paper highlights that while semaglutide is effective for weight loss, it is associated with significant side effects, high cost, and muscle loss. In contrast, natural peptides such as BRP, BPC‐157, and MOTS‐c demonstrate promising anti‐obesity effects with fewer adverse outcomes, improved safety profiles, and potential affordability making them ...
Muhammad Affan Abid+2 more
wiley +1 more source
Yerba mate intake shows cardiometabolic beneficial effects decreasing blood pressure, blood lipids, inflammatory biomarkers and body fat in healthy and hypercholesterolemic non‐habitual consumers. ABSTRACT Yerba mate has been reported to have antihypertensive, hypocholesterolemic, antidiabetic, or antiobesity properties.
Laura Bravo+4 more
wiley +1 more source